Disrupting normative science has become a de rigueur component of the pharmaceutical industry business model. A new pharmaceutical product is not based on need, it is based on market size and profitability. When new data threatens the market of a pharmaceutical product, then that pharma company will try to sprout the seeds of scientific uncertainty and lack of proof.

Dr Robert Malone

#health #disease #natural-health #big-pharma #depopulation